相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pneumocystis jirovecii Pneumonia in Neurologic Disorders Is Prophylaxis Necessary?
Tiffany Pike-Lee et al.
NEUROLOGY-CLINICAL PRACTICE (2021)
Serious infections in patients with myasthenia gravis: population-based cohort study
C. D. Kassardjian et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
Amine Ghembaza et al.
CHEST (2020)
Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Jay A. Fishman et al.
CLINICAL TRANSPLANTATION (2019)
Incidence of pneumocystosis among patients exposed to immunosuppression
Sergey Rekhtman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Health maintenance for adults with neuromuscular diseases on immunosuppression
Sarah L. Cartwright et al.
MUSCLE & NERVE (2019)
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole
Jun Won Park et al.
ARTHRITIS RESEARCH & THERAPY (2019)
INFECTIONS AND THE RELATIONSHIP TO TREATMENT IN NEUROMUSCULAR AUTOIMMUNITY
Devin E. Prior et al.
MUSCLE & NERVE (2018)
Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole
Kazutoshi Yukawa et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2018)
Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study
Liu Yang et al.
BMC NEPHROLOGY (2018)
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
Jun Won Park et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?
Rachel M. Wolfe et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Johan Maertens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
Pierre Fillatre et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
Antoine Roux et al.
EMERGING INFECTIOUS DISEASES (2014)
Rates of Serious Intracellular Infections in Autoimmune Disease Patients Receiving Initial Glucocorticoid Therapy
Kiyoshi Migita et al.
PLOS ONE (2013)
Colonization by Pneumocystis jirovecii and Its Role in Disease
Alison Morris et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis
Richard A. Watts et al.
RHEUMATOLOGY (2012)
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
Andrew H. Limper et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pneumocystis jiroveci Pneumonia in Giant Cell Arteritis: A Case Series
Tanaz A. Kermani et al.
ARTHRITIS CARE & RESEARCH (2011)
Pneumocystis Colonization Is Highly Prevalent in the Autopsied Lungs of the General Population
Carolina A. Ponce et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pneumocystis pneumonia associated with infliximab in Japan
Masayoshi Harigai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients:: Systematic review and meta-analysis of randomized controlled trials
Hefziba Green et al.
MAYO CLINIC PROCEEDINGS (2007)
Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: A retrospective study 2002-2004
Ulrik M. Overgaard et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Opportunistic infections in polymyositis and dermatomyositis
I Marie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Pneumocystis jirovecii in general population
FJ Medrano et al.
EMERGING INFECTIOUS DISEASES (2005)
The epidemiology of myasthenia gravis
LH Phillips
SEMINARS IN NEUROLOGY (2004)
Nonsystemic vasculitic neuropathy - Insights from a clinical cohort
MP Collins et al.
NEUROLOGY (2003)
Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients
F Roblot et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Peripheral blood CD4+T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection
NG Mansharamani et al.
CHEST (2000)
分享论文
